TriSalus Life Sciences Inc. (TLSI) Stock Analysis

TriSalus Life Sciences Inc. (TLSI) is a publicly traded company in the HEALTHCARE sector. It trades at $3.33, carries a market capitalization of $225.40M. This page summarizes the public market data, fundamentals, and frequently asked questions for TLSI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $3.33
• Market Cap: $225.40M
• EPS: $-1.42
• 52-Week High: $7.95
• 52-Week Low: $2.20

Market Sentiment

TriSalus Life Sciences Inc. currently has a Bearish sentiment score of -0.47.

About TriSalus Life Sciences Inc.

None

GNG Research Analysis

GNG Research scores TriSalus Life Sciences Inc. (TLSI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TLSI.

Frequently Asked Questions

Does TLSI pay dividends?

TriSalus Life Sciences Inc. (TLSI) does not currently pay a regular dividend.

What is TLSI's market cap?

TriSalus Life Sciences Inc. (TLSI) has a market capitalization of $225.40M with a current stock price of $3.33.